Login / Signup

Prediction of postoperative disease-free survival and brain metastasis for HER2-positive breast cancer patients treated with neoadjuvant chemotherapy plus trastuzumab using a machine learning algorithm.

Masahiro TakadaMasahiro SugimotoNorikazu MasudaHiroji IwataKatsumasa KuroiHiroyasu YamashiroShinji OhnoHiroshi IshiguroTakashi InamotoMasakazu Toi
Published in: Breast cancer research and treatment (2018)
The DFS and BM models have a high accuracy to predict prognosis among HER2-positive patients treated with NAC plus trastuzumab. Our models can help optimize adjuvant therapy and postoperative surveillance.
Keyphrases